Download
1-s2.0-S2468784720300635-main.pdf 274,12KB
WeightNameValue
1000 Titel
  • Recommendations for the surgical management of gynecological cancers during the COVID-19 pandemic - FRANCOGYN group for the CNGOF
1000 Autor/in
  1. Akladios, Cherif |
  2. Azais, Henri |
  3. Ballester, Marcos |
  4. Bendifallah, Sofiane |
  5. Bolze, Pierre-Adrien |
  6. Bourdel, Nicolas |
  7. Bricou, Alexandre |
  8. Canlorbe, Geoffroy |
  9. Carcopino, Xavier |
  10. Chauvet, Pauline |
  11. Collinet, Pierre |
  12. Coutant, Charles |
  13. Dabi, Yohann |
  14. Dion, Ludivine |
  15. Gauthier, Tristan |
  16. Graesslin, Olivier |
  17. Huchon, Cyrille |
  18. Koskas, Martin |
  19. Kridelka, Frederic |
  20. Lavoue, Vincent |
  21. Lecointre, Lise |
  22. Mezzadri, Matthieu |
  23. Mimoun, Camille |
  24. Ouldamer, Lobna |
  25. Raimond, Emilie |
  26. Touboul, Cyril |
1000 Erscheinungsjahr 2020
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2020-04-01
1000 Erschienen in
1000 Quellenangabe
  • 49(6):101729
1000 Copyrightjahr
  • 2020
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1016/j.jogoh.2020.101729 |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7118621/ |
1000 Publikationsstatus
1000 Begutachtungsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • INTRODUCTION: In the context of the COVID-19 pandemic, specific recommendations are required for the management of patients with gynecologic cancer. MATERIALS AND METHOD: The FRANCOGYN group of the National College of French Gynecologists and Obstetricians (CNGOF) convened to develop recommendations based on the consensus conference model. RESULTS: If a patient with a gynecologic cancer presents with COVID-19, surgical management should be postponed for at least 15 days. For cervical cancer, radiotherapy and concomitant radiochemotherapy could replace surgery as first-line treatment and the value of lymph node staging should be reviewed on a case-by-case basis. For advanced ovarian cancers, neoadjuvant chemotherapy should be preferred over primary cytoreduction surgery. It is legitimate not to perform hyperthermic intraperitoneal chemotherapy during the COVID-19 pandemic. For patients who are scheduled to undergo interval surgery, chemotherapy can be continued and surgery performed after 6 cycles. For patients with early stage endometrial cancer of low and intermediate preoperative ESMO risk, hysterectomy with bilateral adnexectomy combined with a sentinel lymph node procedure is recommended. Surgery can be postponed for 1 to 2 months in low-risk endometrial cancers (FIGO Ia stage on MRI and grade 1-2 endometrioid cancer on endometrial biopsy). For patients of high ESMO risk, the MSKCC algorithm (combining PET-CT and sentinel lymph node biopsy) should be applied to avoid pelvic and lumbar-aortic lymphadenectomy. CONCLUSION: During the COVID-19 pandemic, management of a patient with cancer should be adapted to limit the risks associated with the virus without incurring loss of chance.
1000 Sacherschließung
gnd 1206347392 COVID-19
lokal Introduction
lokal Guideline
lokal Management
lokal Gynaecological cancer
1000 Fächerklassifikation (DDC)
1000 Liste der Beteiligten
  1. https://frl.publisso.de/adhoc/uri/QWtsYWRpb3MsIENoZXJpZg==|https://frl.publisso.de/adhoc/uri/QXphaXMsIEhlbnJp|https://frl.publisso.de/adhoc/uri/QmFsbGVzdGVyLCBNYXJjb3M=|https://frl.publisso.de/adhoc/uri/QmVuZGlmYWxsYWgsIFNvZmlhbmU=|https://frl.publisso.de/adhoc/uri/Qm9semUsIFBpZXJyZS1BZHJpZW4=|https://frl.publisso.de/adhoc/uri/Qm91cmRlbCwgTmljb2xhcw==|https://frl.publisso.de/adhoc/uri/QnJpY291LCBBbGV4YW5kcmU=|https://frl.publisso.de/adhoc/uri/Q2FubG9yYmUsIEdlb2Zmcm95|https://frl.publisso.de/adhoc/uri/Q2FyY29waW5vLCBYYXZpZXI=|https://frl.publisso.de/adhoc/uri/Q2hhdXZldCwgUGF1bGluZQ==|https://frl.publisso.de/adhoc/uri/Q29sbGluZXQsIFBpZXJyZQ==|https://frl.publisso.de/adhoc/uri/Q291dGFudCwgQ2hhcmxlcw==|https://frl.publisso.de/adhoc/uri/RGFiaSwgWW9oYW5u|https://frl.publisso.de/adhoc/uri/RGlvbiwgTHVkaXZpbmU=|https://frl.publisso.de/adhoc/uri/R2F1dGhpZXIsIFRyaXN0YW4=|https://frl.publisso.de/adhoc/uri/R3JhZXNzbGluLCBPbGl2aWVy|https://frl.publisso.de/adhoc/uri/SHVjaG9uLCBDeXJpbGxl|https://frl.publisso.de/adhoc/uri/S29za2FzLCBNYXJ0aW4=|https://frl.publisso.de/adhoc/uri/S3JpZGVsa2EsIEZyZWRlcmlj|https://frl.publisso.de/adhoc/uri/TGF2b3VlLCBWaW5jZW50|https://frl.publisso.de/adhoc/uri/TGVjb2ludHJlLCBMaXNl|https://frl.publisso.de/adhoc/uri/TWV6emFkcmksIE1hdHRoaWV1|https://frl.publisso.de/adhoc/uri/TWltb3VuLCBDYW1pbGxl|https://frl.publisso.de/adhoc/uri/T3VsZGFtZXIsIExvYm5h|https://frl.publisso.de/adhoc/uri/UmFpbW9uZCwgRW1pbGll|https://frl.publisso.de/adhoc/uri/VG91Ym91bCwgQ3lyaWw=
1000 Label
1000 Fördernummer
  1. -
1000 Förderprogramm
  1. -
1000 Dateien
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6419872.rdf
1000 Erstellt am 2020-04-08T12:04:11.989+0200
1000 Erstellt von 122
1000 beschreibt frl:6419872
1000 Bearbeitet von 122
1000 Zuletzt bearbeitet Thu Mar 25 10:16:54 CET 2021
1000 Objekt bearb. Thu Mar 25 10:16:53 CET 2021
1000 Vgl. frl:6419872
1000 Oai Id
  1. oai:frl.publisso.de:frl:6419872 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source